Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
- PMID: 33068628
- PMCID: PMC7557299
- DOI: 10.1016/j.jinf.2020.10.011
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
Abstract
Background: Understanding of the true asymptomatic rate of infection of SARS-CoV-2 is currently limited, as is understanding of the population-based seroprevalence after the first wave of COVID-19 within the UK. The majority of data thus far come from hospitalised patients, with little focus on general population cases, or their symptoms.
Methods: We undertook enzyme linked immunosorbent assay characterisation of IgM and IgG responses against SARS-CoV-2 spike glycoprotein and nucleocapsid protein of 431 unselected general-population participants of the TwinsUK cohort from South-East England, aged 19-86 (median age 48; 85% female). 382 participants completed prospective logging of 14 COVID-19 related symptoms via the COVID Symptom Study App, allowing consideration of serology alongside individual symptoms, and a predictive algorithm for estimated COVID-19 previously modelled on PCR positive individuals from a dataset of over 2 million.
Findings: We demonstrated a seroprevalence of 12% (51 participants of 431). Of 48 seropositive individuals with full symptom data, nine (19%) were fully asymptomatic, and 16 (27%) were asymptomatic for core COVID-19 symptoms: fever, cough or anosmia. Specificity of anosmia for seropositivity was 95%, compared to 88% for fever cough and anosmia combined. 34 individuals in the cohort were predicted to be Covid-19 positive using the App algorithm, and of those, 18 (52%) were seropositive.
Interpretation: Seroprevalence amongst adults from London and South-East England was 12%, and 19% of seropositive individuals with prospective symptom logging were fully asymptomatic throughout the study. Anosmia demonstrated the highest symptom specificity for SARS-CoV-2 antibody response.
Funding: NIHR BRC, CDRF, ZOE global LTD, RST-UKRI/MRC.
Keywords: Anosmia; Antibody; Asymptomatic; COVID-19; Immunity; Population; SARS-CoV-2; Seropoprevalence; UK.
Copyright © 2020. Published by Elsevier Ltd.
Figures
Comment in
-
Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.J Infect. 2021 Nov;83(5):607-635. doi: 10.1016/j.jinf.2021.08.030. Epub 2021 Aug 22. J Infect. 2021. PMID: 34433071 Free PMC article. No abstract available.
References
-
- ONS. Coronavirus (COVID-19) Infection survey pilot – Office for National Statistics. 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/... (accessed June 29, 2020).
-
- Coronavirus (COVID-19) Infections in the community in England – Office for National Statistics. 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/... (accessed July 23, 2020).
-
- Verdi S., Abbasian G., Bowyer R.C.E. TwinsUK: the UK adult twin registry update. Twin Res Hum Genet Off J Int Soc Twin Stud. 2019;6:1–7. - PubMed
-
- COVID Symptom Study - Help slow the spread of COVID-19. 2020. https://covid.joinzoe.com (accessed July 16, 2020).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
